Evestia Clinical (formerly known as EMAS Pharma) has merged with Atlantic Research Group (ARG), a US-based CRO, to create an independent global specialist CRO group in fast-growing markets. The merger expands Evestia Clinical’s global footprint in the U.S. and broadens its therapeutic and services offering to include neurology and late-stage clinical trial services. The enlarged group also provides access to enhanced technologies to further meet the tailored needs of its clients. Evestia C...